Drugs News and Research

RSS

NUS researchers use glowing nanoparticles to control biological processes

The biological technique of 'optogenetics' uses light to control cells within living tissues that have been genetically modified to be light-sensitive.

29 Oct 2019

Scientists solve first structure of human cotransporter protein KCC1

In work that could someday improve treatments for epilepsy, UT Southwestern scientists have published the first three-dimensional structure of a member of a large family of human proteins that carry charged particles – ions – across the cell membrane.

29 Oct 2019

Tell Your Story Even Better with Imaris

The newest release of Imaris, 9.5, was launched earlier this month, enabling users to calculate distance measurements quicker and easier than before, while also offering stunning new rendering tools (Insightful Rendering) to present these measurements and other types of analysis.

From Andor Technology Ltd. 29 Oct 2019

NSU study points to another potential connection between sleep and overall good health

As if you didn't already have enough to worry about to keep you up at night, a new study indicates that poor sleep can negatively affect your gut microbiome, which can, in turn, lead to additional health issues.

29 Oct 2019

Moved overseas for school, stayed for insulin

Every now and then, Katie West considers returning to the United States. She moved to Germany for graduate school three years ago and now works as a health systems researcher in Hamburg. Her family is an ocean away. Then she remembers why she stays.

29 Oct 2019

Anti-inflammatory agents can safely, effectively reduce symptoms of major depression

Anti-inflammatory agents, such as aspirin/paracetamol, statins, and antibiotics, can safely and effectively curb the symptoms of major depression, finds a pooled analysis of the available evidence, published online in the Journal of Neurology Neurosurgery & Psychiatry.

29 Oct 2019

Employers are scaling back their dependence on high-deductible health plans

Everything old is new again. As open enrollment gets underway for next year's job-based health insurance coverage, some employees are seeing traditional plans offered alongside or instead of the plans with sky-high deductibles that may have been their only choice in the past.

29 Oct 2019

Discovery of causal link between hydrogen sulfide and schizophrenia

Researchers from the RIKEN Center for Brain Science in Japan have found certain chemical markers that are associated with schizophrenia. They worked with lab mice with models of schizophrenia as well as post mortem brain specimens of persons with schizophrenia. The study titled, “Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology,” was published in the latest issue of the journal EMBO Molecular Medicine.

28 Oct 2019

Work in progress on medicine for treatment of ulcerative colitis

IKBFU center for clinical research scientists have participated in the international VARSITY clinical research. It's the world's first research aimed at finding the most effective drug among anti-inflammatory ones for the treatment of ulcerative colitis.

28 Oct 2019

Some types of proteins can stabilize damaged DNA

At the University of Copenhagen, researchers have discovered how some types of proteins stabilize damaged DNA and thereby preserve DNA function and integrity. This new finding also explains why people with inborn or acquired defects in certain proteins cannot keep their DNA stable and develop diseases such as cancer.

28 Oct 2019

NCCN ORP plans to support phase II randomized trial for lung cancer patients

The National Comprehensive Cancer Network Oncology Research Program today announced plans to support a phase II randomized trial for lung cancer patients.

28 Oct 2019

Cancer drug may delay progression of bone and other myeloma-related organ damage

The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.

28 Oct 2019

Drugs can be safely delivered to cancerous lymph nodes using sound waves

Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves. Tohoku University researchers tested the treatment on mice with metastatic breast cancer and published their findings in the journal Scientific Reports.

28 Oct 2019

MPST enzyme levels in hair could be a good biomarker for schizophrenia

Working with model mice, post-mortem human brains, and people with schizophrenia, researchers at the RIKEN Center for Brain Science in Japan have discovered that a subtype of schizophrenia is related to abnormally high levels hydrogen sulfide in the brain.

28 Oct 2019

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

Recently, a drug named Pixantrone (PIX) was developed, which is far less damaging to the heart than previous, less advanced compounds. PIX is now used to treat cancers including non-Hodgkin's lymphoma and leukaemia, but a detailed knowledge of the molecular processes it uses to destroy cancer cells has been lacking so far.

28 Oct 2019

New cystic fibrosis drug now available through NHS England

On October 24, 2019, cystic fibrosis (CF) patients rejoiced at the news that three years of talks between the UK’s National Institute for Health and Care Excellence (NICE) and Vertex Pharmaceuticals had succeeded in a compromise which could see about 5,000 patients gaining access to a potentially life-saving drug called Orkambi within the next month. Orkambi is perceived to be a ‘wonder drug’ because it helps these patients to breathe easier and better, and can be started as young as two years.

28 Oct 2019

Large gap between norms and actual quality of primary care in Canadian kidney patients

Chronic kidney disease (CKD) is a condition commonly encountered in primary health care the world over. However, a new study published in JAMA Network on September 4, 2019, shows that the standard of primary care is quite variable.

26 Oct 2019

Rutgers expert offers advice to avoid risks of Halloween poisoning and allergic reactions

About 41.1 million children in the United States trick-or-treat on Halloween night. Bruce Ruck, managing director of the New Jersey Poison Control Center at Rutgers New Jersey Medical School's Department of Emergency Medicine, offers the following advice to avoid the risks of poisoning and allergic reactions.

25 Oct 2019

New injectable formula to treat joint inflammation has sustained effect for ten days

Thanks to a new injectable formula, Brazilian researchers have succeeded in enhancing the efficacy and prolonging the duration of action of a drug commonly used to treat joint inflammation.

25 Oct 2019

Society for Maternal-Fetal Medicine releases statement in response to PROLONG trial results

The Society for Maternal-Fetal released the following statement in response to the published results of "Progestin's Role in Optimizing Neonatal Gestation," more commonly referred to as the PROLONG trial, which was recently published in the American Journal of Perinatology.

25 Oct 2019

Drugs News and Research

NUS researchers use glowing nanoparticles to control biological processes

Scientists solve first structure of human cotransporter protein KCC1

Tell Your Story Even Better with Imaris

NSU study points to another potential connection between sleep and overall good health

Moved overseas for school, stayed for insulin

Anti-inflammatory agents can safely, effectively reduce symptoms of major depression

Employers are scaling back their dependence on high-deductible health plans

Discovery of causal link between hydrogen sulfide and schizophrenia

Work in progress on medicine for treatment of ulcerative colitis

Some types of proteins can stabilize damaged DNA

NCCN ORP plans to support phase II randomized trial for lung cancer patients

Cancer drug may delay progression of bone and other myeloma-related organ damage

Drugs can be safely delivered to cancerous lymph nodes using sound waves

MPST enzyme levels in hair could be a good biomarker for schizophrenia

Molecular mechanisms involved in Pixantrone's interactions with cancer DNA discovered

New cystic fibrosis drug now available through NHS England

Large gap between norms and actual quality of primary care in Canadian kidney patients

Rutgers expert offers advice to avoid risks of Halloween poisoning and allergic reactions

New injectable formula to treat joint inflammation has sustained effect for ten days

Society for Maternal-Fetal Medicine releases statement in response to PROLONG trial results

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News